Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) stock price, financials & research

Regular session · HKT · Market data may be delayed.

Company profile

Beijing Tong Ren Tang Chinese Medicine Company Limited, encompassing its various affiliates, specializes in the production, distribution, and direct sale of traditional Chinese medicine and wellness items, catering to both corporate distributors and individual consumers. Its operations are geographically segmented across Hong Kong, Mainland China, and international markets. Additionally, the company provides traditional Chinese medical consultations and therapeutic services. The firm maintains a network of 23 retail stores throughout Hong Kong, complemented by 46 international outlets located across Asia, Oceania, North America, and Europe. All its offerings are sold under the well-recognized Tong Ren Tang brand. Established in 1669, the company's main office is situated in Wan Chai, Hong Kong.

Industry: Medical - Pharmaceuticals
Sector: Healthcare
Headquarters: HK
CEO: Wang Chi
Listed since: May 7, 2013
Employees: 780

Market position

Day range

Current HK$6.355

HK$6.295HK$6.42

52-week range

Current HK$6.355

HK$6.21HK$9.72

Open: HK$6.37
Previous close: HK$6.395
Volume: 967.19K; 1.04× average
Average volume: 932.7K; Average daily volume
Market cap: 5.32B HKD
Beta: 0.36; Market reference 1
50-day average: HK$6.6446; -4.36% below average
200-day average: HK$7.8513; -19.06% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM): 13.41×
P/B (TTM): 1.27×
P/S (TTM): 3.52×
Dividend yield: 6.29%

Profitability & efficiency

Gross margin: 61.16%
Operating margin: 31.20%
Net margin: 26.25%

Financial health

Debt / equity: 0.03×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

1.51B HKD-6.10%

Operating income

472.24M HKD-18.15%

Net income

397.22M HKD-20.60%

Metric (HKD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.51B HKD	1.61B HKD	1.52B HKD	1.73B HKD	1.56B HKD
Cost of goods sold	587.78M HKD	546.32M HKD	477.7M HKD	580.96M HKD	436.54M HKD
Gross profit	925.58M HKD	1.07B HKD	1.05B HKD	1.15B HKD	1.12B HKD
Research and development	11.62M HKD	9.13M HKD	12.21M HKD	7.7M HKD	11.27M HKD
Selling, general, and administrative	390.41M HKD	492M HKD	410.29M HKD	341.68M HKD	341.68M HKD
Operating expenses	453.34M HKD	488.41M HKD	423.09M HKD	338.57M HKD	341.16M HKD
Interest income	46.84M HKD	57.27M HKD	72.88M HKD	20.59M HKD	4.38M HKD
Interest expense	5.66M HKD	6.48M HKD	5.98M HKD	4.66M HKD	4.71M HKD
Depreciation and amortization	19.53M HKD	88.12M HKD	82.51M HKD	75.47M HKD	69.97M HKD
Operating income	472.24M HKD	576.92M HKD	624.15M HKD	811.58M HKD	778.46M HKD
Net income	397.22M HKD	500.28M HKD	540.39M HKD	645.88M HKD	607.84M HKD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate: 0%; 0 beats, 2 misses, 0 met estimates
Average EPS surprise: -60.87%; 2 comparable reports
Latest EPS result: 0.28

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.35

2025 complete year+45.8% since 2021

2026 partial: HK$0.40

HK$0.24

2,021

HK$0.53

2,022

HK$0.33

2,023

HK$0.33

2,024

HK$0.35

2,025

HK$0.40

2,026*

* Partial calendar year in the available dividend history.

Corporate action history

Action	Ex-dividend date	Details	Record date	Payment date
Dividend	Jun 12, 2026	HK$0.40Special	Jun 15, 2026	Jun 26, 2026
Dividend	Jun 5, 2025	HK$0.35Irregular	Jun 6, 2025	Jun 18, 2025
Dividend	Jun 12, 2024	HK$0.33Annual	Jun 13, 2024	Jun 24, 2024
Dividend	May 10, 2023	HK$0.33Annual	May 11, 2023	May 31, 2023
Dividend	Oct 6, 2022	HK$0.25Special	Oct 7, 2022	Oct 21, 2022
Dividend	Jun 14, 2022	HK$0.28Annual	Jun 15, 2022	Jun 30, 2022